The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders
Autor: | Christine Grabrucker, Helga Schmetzer, Anja Liepert, Andreas Kremser, Nina Scholl, Helmut R. Salih, Hans-Jochem Kolb, Julia Loibl |
---|---|
Rok vydání: | 2009 |
Předmět: |
Cancer Research
Myeloid Cell Biology chemistry.chemical_compound Immune system hemic and lymphatic diseases Tumor Cells Cultured medicine Humans Myeloid Cells Lymphocytes Lymphoma Non-Hodgkin Myeloid leukemia Dendritic Cells Hematology Ligand (biochemistry) medicine.disease Lymphoma Leukemia Myeloid Acute Haematopoiesis 4-1BB Ligand 4-1BB ligand medicine.anatomical_structure Solubility Oncology chemistry Hematologic Neoplasms Myelodysplastic Syndromes Antigens Surface Immunology Cancer research |
Zdroj: | Leukemia & Lymphoma. 50:427-436 |
ISSN: | 1029-2403 1042-8194 |
DOI: | 10.1080/10428190802709453 |
Popis: | The TNFR family member 4-1BB and its ligand 4-1BBL are involved in the costimulation of T-cells and tumor-derived soluble (s)4-1BBL may influence the interaction of malignant cells with the immune system. Here, we report that cell-surface-expressed (c)4-1BBL can be expressed on mononuclear blood cells from patients with acute myeloid leukemia (AML) (n = 35), myelodysplasia (n = 5) or non-Hodgkin lymphoma (n = 11) and can be coexpressed on varying proportions of lymphoid or myeloid malignant cells and on dendritic cells differentiated from AML-blasts. Direct correlations between c- and s4-1BBL were not found in the investigated cases. Up to now expression of 4-1BBL has not been described on primary myeloid malignant cells, but only on malignant cells of lymphoid or solid tumor origin or on tumor cell lines. With our work we further contribute to the understanding of the potential role of c/s4-1BBL in immune reactions and its influence on the interaction of tumor and immunoreactive cells. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |